National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

temsirolimusPatient Information
An ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Cell Cycle Inhibitor 779
Rapamycin Analog
Rapamycin Analog CCI-779
US brand name:Torisel
Code name:CCI-779
Chemical structure name:42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin



Previous:telomerase: 540-548 peptide vaccine, teloxantrone hydrochoride, Temodar, temozolomide, Tempostatin
Next:teniposide, tenofovir, terameprocol, terephthalamidine, teroxirone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov